bpc 157 esophagus Frontiers Stable Gastric Pentadecapeptide BPC 157
Description
Animals receiving BPC-157 demonstrated progressive restoration of motor activity, reduced abnormal pain-related behaviors, and resolution of spastic symptoms within two weeks
The founding metabolic study (obese Zucker rats)
Taking more than intended causes increased gastrointestinal side effects, primarily nausea, vomiting, and diarrhea
Cognitive Issues: Difficulty concentrating, forgetfulness, or mental fog may develop over time
As such, individuals considering its use should consult healthcare professionals and consider the legal implications of acquiring peptides for personal use
Inspection: Before each use, inspect the solution for clarity
